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Available online 31 May 2016Episodic ataxia 2 (EA2) is an autosomal dominant disorder caused by mutations in the gene CACNA1A that en-
codes the pore-forming CaV2.1 calcium channel subunit. The majority of EA2 mutations reported so far are non-
sense or deletion/insertion mutations predicted to form truncated proteins. Heterologous expression of wild-
type CaV2.1, together with truncated constructs that mimic EA2mutants, signiﬁcantly suppressed wild-type cal-
cium channel function, indicating that the truncated protein produces a dominant-negative effect (Jouvenceau et
al., 2001; Page et al., 2004). A similar ﬁnding has been shown for CaV2.2 (Raghib et al., 2001).We showhere that a
highly conserved sequence in the cytoplasmic N-terminus is involved in this process, for both CaV2.1 and CaV2.2
channels. Additionally, wewere able to interferewith the suppressive effect of an EA2 construct bymutating key
N-terminal residues within it. We postulate that the N-terminus of the truncated channel plays an essential part
in its interaction with the full-length CaV2.1, which prevents the correct folding of the wild-type channel. In
agreement with this, we were able to disrupt the interaction between EA2 and the full length channel by co-ex-
pressing a free N-terminal peptide.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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CaV2.1 (P/Q-type) and CaV2.2 (N-type) channels are voltage-gated
calcium channels that are expressed in both the central and peripheral
nervous system, where they are preferentially localized in presynaptic
terminals and play a central role in neurotransmitter release (Turner
et al., 1993). Mutations in the CACNA1A gene that encodes the pore-
forming CaV2.1 α1 subunit cause three neurological disorders: familial
hemiplegic migraine type 1 (FHM1), spinocerebellar ataxia type 6
(SCA6) and Episodic ataxia 2 (EA2) (Pietrobon, 2010). EA2 is a rare au-
tosomal dominant disorder characterized by prolonged episodes of
ataxia, which are commonly triggered by emotional and physical stress
(Jen, 2008). Interestingly, while all FHM1mutations reported so far are
missense mutations, localized to important functional regions of CaV2.1
such as the pore and the voltage sensors, EA2 is frequently associated
with nonsense, deletion or insertion mutations (Jeng et al., 2008;sodic ataxia 2; FHM1, familial
a type 6; TAT, transactivator of
), a.dolphin@ucl.ac.uk
ect.com).
. This is an open access article underMantuano et al., 2010). Indeed themajority of EA2mutations described
to date are predicted to form truncated proteins resulting froma prema-
ture stop codon (Pietrobon, 2010).
It has been found that the functional expression of the full-length
CaV2.1 channel is substantially suppressed when it is co-expressed
with truncated constructs mimicking EA2 mutations (Jouvenceau et
al., 2001; Page et al., 2004), indicating that EA2 may not be simply a re-
sult of haploinsufﬁciency. Furthermore, heterologous expression of the
wild-type CaV2.2 channel together with corresponding truncated con-
structs similarly suppressed wild-type channel function (Raghib et al.,
2001). Our evidence suggests that the truncated proteins are recognized
asmisfolded proteins, and retained in the endoplasmic reticulumwhere
they trigger endoplasmic reticulum stress (Page et al., 2004), and are
also targeted for proteasomal degradation (Mezghrani et al., 2008). Fur-
thermore, the suppression effect requires interaction between the full-
length and the mutant protein, to induce both synthesis arrest and
channel degradation, thereby reducing functional expression of the
full-length channel (Mezghrani et al., 2008; Page et al., 2004).
Strikingly, the suppressive effect mediated by the truncated channel
proteins has also been described for other calcium channels and may
play a physiological role in regulating current density. Indeed, two-do-
main truncated forms of CaV1.2 channel have been identiﬁed. These
splice variants are predominantly expressed in fetal and neonatal rat
heart (Wielowieyski et al., 2001). Furthermore a truncated two domainthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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2002). Moreover, a truncated CaV1.3 splice variant, Cav1.3 33 L,
consisting of Dom I, II, III and a portion of domain IV, affects the function
of the full-length channel (Liao et al., 2015). Thus, the suppressive effect
of the truncated protein appears to play a physiological role in regulat-
ing CaV1.3 function during cardiac development (Liao et al., 2015). Re-
cently, CaV1.2 was also shown to undergo proteolytic cleavage
resulting in two complementary fragments. This mid-channel proteoly-
sis is described as an activity-dependent feedback inhibition of voltage-
dependent calcium channels (Michailidis et al., 2014).
For both CaV2.1 and CaV2.2 it has been shown that a motif in the N-
terminus plays an important role in channel function and modulation
by second messengers (Page et al., 1998). Initially, it was established
that the substitution of just two arginine residues in this motif
completely abolished G-protein modulation (Canti et al., 1999). Later,
this motif was also found to be essential for the process underlying
dominant-negative suppression of CaV2.1 and CaV2.2 currents (Page et
al., 2010).
In this study we wished to explore whether overexpressing these
key N-terminal residues as a separate peptide would impede the dom-
inant-negative effect of the truncated EA2 protein, and thus restore
the function of the wild-type CaV2.1 channels. If so, this would provide
a potential route towards therapeutic intervention.
2. Materials and methods
2.1. Molecular biology and constructs
The following cDNAs were used: rabbit CaV2.2 HA (Cassidy et al.,
2014), rat CaV2.1 (GenBank Accession number M64373 with E1686R
mutation) (Page et al., 2004), rat α2δ-1 (GenBank Accession number
M86621), rat β1b (Tomlinson et al., 1993), CaV2.2 Dom I–II (Raghib et
al., 2001), EA2 mutant CaV2.1-P1217fs (Page et al., 2004) CaV3.1 Dom
I–II (Page et al., 2004), and GFP-CAAX (Page et al., 2010). Other cDNAs
were made using standard cloning techniques as follows: CaV2.2R52A,
R54A HA, corresponding to the full-length CaV2.2 contains R52A, R54A
mutations and an exofacial HA tag. CaV2.2 Dom I–IIR52A, R54A corre-
sponds to the truncated CaV2.2 with R52A, R54A mutations.
CaV2.1R57A, R59A and EA2R57A, R59A corresponds to the full-length and
truncated CaV2.1 with R52A, R54A mutations. For CaV2.2 Dom I–II HA
and CaV2.2 Dom I–IIR52A, R54A HA, the exofacial HA tag was inserted as
in CaV2.2 HA (Cassidy et al., 2014). CaV2.1-(46-100)-CAAX and CaV2.2-
(43-95)-CAAX correspond to the truncated N-terminal constructs, in
which a CAAX motif was added to the C-terminus (Page et al., 2010).
All the cDNAs have been veriﬁed by sequencing.
2.2. Cell culture and heterologous expression
The electrophysiological studies were performed in tsA-201 cells.
The cells were cultured in Dulbecco's modiﬁed Eagle's medium
(DMEM) supplemented with 10% fetal bovine serum, 1% Glutamax
and 50 U/mL penicillin, 50 μg/mL streptomycin. The cells were
transfected using FuGENE 6 in a ratio of 6:2 to DNA. The cDNAs of
CaV2.1,α2δ-1, β1b, the truncated domains and CD8 (transfection mark-
er) were mixed in a ratio of 3:2:2:3:0.8. For the experiments where the
effect of the N-terminus had been assessed, the DNA mixes contained
CaV2.1, α2δ-1, β1b, the truncated N-terminus constructs and CD8 in a
ratio of 3:2:2:3:0.8. Finally to examinewhether theN-terminus residues
could restore the channel function, CaV2.1was co-transfectedwithα2δ-
1, β1b, EA2, N-terminus constructs and CD8 (ratio 3:2:2:3:3:0.8).
For co-immunoprecipitation experiments, tsA-201 cells were
transfected with CaV2.2 HA, α2δ-1, β1b, CaV2.2 Dom I–II and CaV2.2-
(43-95)-CAAX in a ratio of 3:2:2:3:3. In control experiments, CaV3.1
Dom I–II was used in place of CaV2.2 Dom I–II or GFP-CAAX was used
in place of CaV2.2-(43-95)-CAAX. When neither GFP-CAAX nor CaV2.2-(43-95)-CAAX was included in the mix, the cDNA was maintained at
2 μg total by including empty pMT2 vector.
Neuro2A mouse neuroblastoma cells were used for the immunocy-
tochemistry experiments. They were maintained in DMEM/Opti-MEM,
5% fetal bovine serum, 1% Glutamax, 50 U/mL penicillin and 50 μg/mL
streptomycin. The cells were seeded on poly-L-lysine coated coverslips
(0.25 mg/mL, Sigma-Aldrich) and were transfected with PolyJet, in a
ratio of 3:1 to DNA. The DNA mixes consisted of pMT2 CaV2.2 HA,
pcDNA3 α2δ-1, pRK5 β1b and truncated domains in a ratio of 2:1:1:2.
2.3. DRG neuron preparation
The preparation of cultured dorsal root ganglion (DRG) neuronswas
performed as described previously (D'Arco et al., 2015). Brieﬂy, DRG
neurons isolated from P10 Sprague-Dawley rats were transfected by
nucleofection following the manufacturer's instructions (Program G-
13, Lonza). The cells were transfected with pcDNA3 empty vector and
YFP for the control condition in a 4:0.8 ratio, or with pcDNA3-EA2, YFP
and either pCDNA3 empty vector or pcDNA3 CaV2.1-Nter-46-100-
CAAX in a 2:2:0.8 ratio (2 μg of total DNA in all cases). DRGs were
then plated on poly-L-lysine-coated coverslips (0.25 mg/mL, Sigma-Al-
drich) and cultured in DMEM-F12 (Invitrogen) containing 10% FBS
and 50 ng/mL NGF.
2.4. Electrophysiology
Whole-cell patch-clamp recordings were performed on tsA-201
cells 48 h after transfection and DRG neurons 4 days after transfection,
at room temperature. The cells were replated prior to voltage-clamp ex-
periments. Brieﬂy, the neuronswere incubated in a collagenase solution
(0.2 mg/mL in serum free DMEM-F12) at 37 °C for 10 min. Neurons
were then resuspended in DMEM-F12/FBS and plated on poly-L-ly-
sine-coated coverslips. tsA-201 cells were dissociated using a non-enzy-
matic dissociation reagent (Sigma), resuspended in DMEM and plated
on 35 mm dishes. Voltage-clamp experiments were performed 2–6 h
after replating. For tsA-201 cells, patch pipettes were ﬁlled with a solu-
tion containing the following (in mM): 140 Cs-aspartate, 5 EGTA, 2
MgCl2, 0.1 CaCl2, 2 K2ATP and 10 HEPES, titrated to pH 7.2 with CsOH.
The external solution contained the following (in mM): 150
tetraethylammonium bromide, 3 KCl, 1 NaHCO3, 1 MgCl2, 10 HEPES, 4
Glucose and 1 BaCl2, pH adjusted to 7.4 with Tris base. For the DRG re-
cordings, the external solution contained the following (in mM): 150
tetraethylammonium bromide, 3 KCl, 1 NaHCO3, 1 MgCl2, 10 HEPES, 4
Glucose and 5 BaCl2, 1 μM Tetrodotoxin (TTX), 1 μM nifedipine and
1 μM ω-conotoxin GVIA to isolate the native P/Q type calcium currents.
The currentswere recorded using an Axopatch 200B ampliﬁer (Axon in-
struments). Data were acquired with Clampex 8.2 and analysed with
Clampﬁt 10.2 and Origin 7 software.
2.5. Immunocytochemistry
48 h after transfection, the Neuro-2a cells were washed twice with
PBS and ﬁxed with 4% paraformaldehyde (PFA) for 10 min. The cells
were then incubated with rat anti-HA antibody (Roche) at a dilution
of 1:500 in PBS with 1% Bovine Serum Albumin (BSA) for 1 h at room
temperature. The cells were washed and incubated with a secondary
anti-rat antibody conjugated to ﬂuorescein isothiocyanate. Detection
of the intracellular channel pool following surface labelling was per-
formed after cell permeabilization with 0.2% Triton X-100 for 10 min.
The coverslips were then washed with PBS and incubated with rabbit
anti-Cav2.2 antibody (polyclonal, afﬁnity-puriﬁed antibody directed
against the intracellular II–III linker) at a dilution of 1:500 for 1 h in
PBS with 1% BSA. The cells were then incubated with secondary anti-
body, anti-Rabbit Alexa 594 (Abcam) at a dilution of 1:500.
Four days after transfection, the DRG neurons were washed and
ﬁxed with 4% PFA for 10 min. The neurons were then permeabilized
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blocking solution containing 10% goat serum (GS) and 5% BSA, for
30 min. The primary anti-CaV2.1 antibody (Alomone Labs) in PBS, con-
taining 5% GS and 2.5% BSA, was applied at 4 °C overnight. The cells
were washed and the secondary antibody anti-rabbit Alexa 594
(Abcam) was applied in PBS containing 5% GS and 2.5% BSA, for 1 h at
room temperature. For all cells, the coverslips were washed and
mounted on slides using Vectashield (Vector Laboratories) to reduce
photobleaching. Imaging was performed using a confocal laser-scan-
ning microscope (Zeiss).
Cell surface expression was measured using ImageJ, by manually
tracing the surface of the cells represented by the HA signal. The back-
ground signal was measured in an area of the image lacking cells and
subtracted from the measurements.
2.6. Immunoprecipitation and western-blotting
Cells were lysed using 1% Igepal in PBS in the presence of 25 mM N-
ethylmaleimide (NEM) and protease inhibitors for 30 min on ice, and
whole cell lysates (WCL) were collected after centrifugation
(14,000 ×g, for 30min at 4 °C). The total protein concentration was de-
termined (Bradford assay, Bio-Rad) for each sample. For co-immuno-
precipitation, WCL (containing 1 mg protein) was pre-cleared on
30 μL protein A/G Plus Agarose (Santa Cruz) for 2 h at 4 °C. Agarose
beads were discarded and supernatants were incubated with rat anti-
HA (Roche) at a dilution of 1:100 overnight at 4 °C. Immunoprecipitated
proteins were captured on 50 μL of protein A/G beads for 2 h at 4 °C. The
beads were washed three times with PBS containing 0.1% Igepal. The
beads, as well as the WCL samples, were incubated for 15 min at 55 °C
with 100 mMDTT, 25 mMNEM and 2× Laemmli sample buffer. Eluted
co-immunoprecipitated proteins and WCL samples were resolved by
SDS–PAGE 3–8% Tris-Acetate gels and then transferred to
polyvinylidene ﬂuoride membranes. Membranes were incubated in
blocking buffer (10 mM Tris pH 7.4, 500 mM NaCl, 0.5% Igepal and 3%
BSA) for 1 h, followed by incubation with rabbit anti-CaV2.2 (against
the II–III loop) overnight at a dilution of 1:1000 at 4 °C. The secondary
antibody, goat anti-rabbit coupled to horseradish peroxidise, was incu-
bated at a dilution of 1:2000 for 1 h at room temperature. Proteins
were detected using the enhanced ECL Plus reagent (GE Healthcare)
on a Typhoon 9410 scanner (GE Healthcare).
2.7. Statistical analysis
Statistical analysis between groups was performed using one-way
ANOVA with Bonferroni post-hoc test, using Graphpad Prism software.
Statistical analysis between two groups (Fig. 4) was carried out using
Student's t test.
3. Results
3.1. Lack of cell surface expression of truncated channels
The CaV2.1 and CaV2.2 N-termini show a high degree of homology
(Fig. 1A). Here we assessed the role of the two conserved arginine resi-
dues (indicated by the red rectangles in Fig. 1A) in the dominant-nega-
tive suppression of CaV2 channels by truncated two domain constructs.
We initially monitored the surface expression of the full-length and
truncated CaV2.2 harbouring an exofacial HA tag (Cassidy et al., 2014),
co-expressed with the auxiliary subunits α2δ-1 and β1b. CaV2.2 was
used to monitor cell surface expression, since in our hands CaV2.1
with an exofacial tag (Watschinger et al., 2008) was not well exposed
on the cell surface. While the full-length CaV2.2 channel was found to
be expressed on the cell surface of non-permeabilized Neuro2A cells,
as shown by the HA signal (Fig. 1B), a truncated CaV2.2 construct,
consisting of Dom I–II and the II–III loop was retained intracellularly,
and no surface HA signal was detected (Fig. 1B). CaV2.2 Dom I–IIR52A,R54A, in which the key arginine residues identiﬁed in Fig. 1A were
substituted by alanine, was also not trafﬁcked to the surface (Fig 1B).
The fact that the truncated two domain CaV2.2 constructs are not
expressed at the cell surface is not surprising as it has already been
shown that the truncated mutant CaV2.1 channels alone do not form
functional channels (Jouvenceau et al., 2001). However, for CaV2.2 and
CaV1.2, co-expression of complementary truncated domain pairs was
found to give rise to currents, although their amplitude was smaller
than the full-length channel current (Raghib et al., 2001; Michailidis et
al., 2014), indicating that channel fragments can interact and fold ap-
propriately, when all the domains are present.3.2. Role of the N-terminal arginine motif in the suppressive effect of trun-
cated channels
Wenext examined the suppressive effect of the truncated constructs
on CaV2.1 and CaV2.2 channel function and trafﬁcking. We ﬁrst investi-
gated the effect of the substitution of R57A, R59A in an EA2 mutant
(CaV2.1-P1217fs), containing only the ﬁrst two domains and the intra-
cellular II–III loop; this mutant will be referred as EA2 throughout the
paper. In all our studies, the equivalent ﬁrst two domains of CaV3.1
were used as a negative control as this was shown previously not to
cause dominant-negative inhibition of CaV2.2 channels (Page et al.,
2010). This was also found in the present study for CaV2.1 as shown
by the unchanged current densities at +5 mV in the presence of either
CaV3.1 Dom I–II (−66.6 ± 8.0 pA/pF) or GFP-CAAX (−75.3 ± 13.0 pA/
pF) (data from Fig. 2C and Fig. 5C).
As shown in Fig. 2A–C, while the EA2mutant exerted a strong dom-
inant-negative effect, signiﬁcantly reducing CaV2.1 current density at
+5 mV by 63% (control: −66.6 ± 8.0 pA/pF; EA2: −27.4 ± 4.8 pA/
pF), the EA2R57A, R59A construct (−47.2 ± 9.6 pA/pF) produced a non-
signiﬁcant dominant-negative inhibition (Fig. 2C). There was no differ-
ence in the voltage for 50% activation (V50) (data not shown). This dif-
ferential effect was conﬁrmed for cell surface expression of full-length
CaV2.2, which was signiﬁcantly reduced by co-expression with CaV2.2
Dom I–II but not with CaV2.2 Dom I–IIR52A, R54A (Fig. 2D, E). This con-
ﬁrms that the N-terminal RAR motif in CaV2.1 and CaV2.2 is involved
in the process underlying the dominant-negative suppression by the
truncated channels.
We next used full-length channel constructs carrying the arginine-
to-alanine substitutions (CaV2.1R57A, R59A and CaV2.2R52A, R54A), and
assessed the dominant-negative effect of the truncated constructs. As
shown in Fig. 3A–C, co-expression of the EA2 mutant signiﬁcantly re-
duced CaV2.1R57A, R59A current by 60% (control:−93.5 ± 15.0 pA/pF;
EA2:−37.5±6.3 pA/pF), indicating that the full-length channel still in-
teracts with the EA2mutant despite the fact that its own argininemotif
was disrupted. However there was still a dominant-negative effect
when CaV2.1R57A, R59A was co-expressed with EA2R57A, R59A (−61.1 ±
6.4 pA/pF), albeit reduced compared to the EA2 condition (Fig. 3B). It
is of interest that CaV2.1R57A, R59A exhibited larger currents than wild-
type CaV2.1 (Fig. 3C, compared to Fig. 2C), suggesting that there may
be a tonic inhibitory effect that is relieved by mutating the N-terminus.
Similar ﬁndings were obtained for cell surface expression of CaV2.2.
The cell surface expression of full-length CaV2.2R52A, R54A was signiﬁ-
cantly reduced by CaV2.2 Dom I–II, and also by CaV2.2 Dom I–IIR52A,
R54A (Fig. 3D, E).
Thus the RAR motif in the N-terminus of the truncated two do-
main constructs, but not the full-length channels, is directly involved
in the suppressive effect of the truncated constructs. Because this in-
hibition is mediated by the interaction between the full-length and
truncated constructs, we hypothesised that the N-terminus of the
truncated construct is essential for the truncated channels to interact
with the full-length channels. We therefore tested whether the co-
expression of the key N-terminal peptide would prevent this delete-
rious interaction.
Fig. 1. Comparison of CaV2.1 and CaV2.2 N-termini sequences and expression of truncated domains. (A) The sequences were aligned with DNASTAR program using Clustal V. Gaps are
shown as (–), identical amino acids are indicated as ‘*’. The conserved arginine residues are indicated by red rectangles. (B) Representative confocal images of Neuro2A cells
expressing CaV2.2 HA (top), CaV2.2 Dom I–II HA (middle) and CaV2.2 Dom I–IIR52A, R54A HA (bottom). Surface staining was obtained by using HA antibody before cell permeabilization
(left panel). The intracellular CaV2.2 constructs were detected in permeabilized cells using a CaV2.2 antibody that targets the II–III loop (middle panel). The merged images are shown
in the right panel. Scale bar; 20 μm.
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the full-length CaV2.2 with the truncated domains
In this study we used an N-terminal construct with a CAAX
myristoylation motif attached to its C-terminus to allow its association
with intracellular lipid bilayers (Page et al., 2010). AnN-terminally trun-
cated N-terminus construct still containing the RARmotif was used, as it
has been shown that the full-length N-terminus itself signiﬁcantly re-
duced calcium currents (Page et al., 2010). In CaV2.2-(43-95)-CAAX,
the ﬁrst 42 residues containing the glycine-rich region were removed
(Fig. 1A).
We performed co-immunoprecipitation experiments to determine if
CaV2.2-(43-95)-CAAX interferes with the association of full-length
CaV2.2 HA with CaV2.2 Dom I–II. WCL were immunoprecipitated withHA antibody and then probed with a CaV2.2 antibody that targets the
II–III loop, present in both the full-length and the truncated channel
(Fig. 4A). As shown in Fig. 4, full-length CaV2.2 HAwas able to co-immu-
noprecipitate CaV2.2Dom I–II (Fig. 4A, band indicated in lane 2). CaV2.2-
(43-95)-CAAX (lane 4), but not GFP-CAAX used as a control (lane 3), in-
terfered with the interaction between full-length CaV2.2 HA and CaV2.2
Dom I–II, as indicated by the absence of the band corresponding to
CaV2.2 Dom I–II in lane 4 (Fig. 4A). Three independent experiments
were performed and the bands corresponding to CaV2.2 Dom I–II were
quantiﬁed and normalised to full-length CaV2.2 expression for each con-
dition, in both co-immunoprecipitation andWCLwestern-blots (Fig. 4A,
B). The mean data (Fig. 4C) show the normalised values with respect to
the CaV2.2 HA+CaV2.2 Dom I–II condition (lane 2 in Fig. 4A and B). The
results show that Dom I–II co-immunoprecipitation with CaV2.2 was
Fig. 2. Effect of truncated domains on CaV2 channel expression. (A–C) Effect of the truncateddomains on CaV2.1 currents. tsA-201 cells expressed full-length CaV2.1with CaV3.1Dom I–II as
a control (black, control), EA2 (red) or EA2R57A, R59A (blue), together with α2δ-1 and β1b subunits. (A) Representative traces for the three conditions were evoked by 50 ms step
depolarizations between −50 and +60 mV from a holding potential of −80 mV. The currents are normalised to the cell capacitance. (B) Mean current-voltage relationships for
CaV2.1 with CaV3.1 Dom I–II (black squares, control), CaV2.1 with EA2 (red circles) or CaV2.1 with EA2R57A, R59A (blue circles). (C) Bar chart of mean current densities (pA/pF) at
+5 mV ± SEM for CaV2.1 with CaV3.1 Dom I–II (black, control, n = 20), CaV2.1 with EA2 (red, n = 24) and CaV2.1 with EA2R57A, R59A (blue, n = 21). Statistical analysis *p b 0.05 vs
control. (D–E) Effect of the truncated constructs on CaV2.2 HA cell surface expression. Neuro2A cells expressed full-length CaV2.2 with CaV3.1 Dom I–II, CaV2.2 Dom I–II or CaV2.2 Dom
I–IIR52A, R54A, together with α2δ-1 and β1b subunits. (D) Three examples of confocal images of Neuro2A cells expressing CaV2.2 HA with CaV3.1 Dom I–II (top), CaV2.2 HA with CaV2.2
Dom I–II (middle) or CaV2.2 HA and CaV2.2 Dom I–IIR52A, R54A (bottom). Surface staining was obtained by using HA antibody in non-permeabilized cells. (E) Cell surface expression of
CaV2.2 was quantiﬁed based on the HA signal. Bar chart of mean of cell surface expression ± SEM for CaV2.2 HA with CaV3.1 Dom I–II (black, control), CaV2.2 HA with CaV2.2 Dom I–II
(red) or CaV2.2 HA with CaV2.2 Dom I–IIR52A, R54A (blue). The data were pooled from 4 independent experiments; more than 100 cells were included in the analysis for each condition.
Statistical analysis: ***p b 0.001 vs control.
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Fig. 3. Effect of truncated domains on N-terminally mutated CaV2 channel expression. (A-C) Effect of the truncated constructs on CaV2.1R57A, R59A currents. (A) tsA-201 cells were co-
transfected with full-length CaV2.1R57A, R59A/α2δ-1/β1b and CaV3.1 Dom I–II (control, black), EA2 (red) or EA2R57A, R59 (blue). Representative traces were evoked by 50 ms step
depolarizations between −50 and +60 mV from a holding potential of −80 mV. The currents are normalised to the cell capacitance. (B) Mean current-voltage relationships for
CaV2.1R57A, R59A and CaV3.1 Dom I–II (black squares, control), CaV2.1R57A, R59A and EA2 (red circles) or CaV2.1R57A, R59A and EA2R57A, R59A (blue circles). (C) Mean current densities (pA/
pF) at +5 mV ± SEM for CaV2.1R57A, R59A with CaV3.1 Dom I–II (black, control, n = 10), CaV2.1R57A, R59A with EA2 (red, n = 18) or CaV2.1R57A, R59A with EA2R57A, R59A (blue, n = 13).
Statistical analysis: *p b 0.05, ***p b 0.001 vs control. (D–E) Effect of the truncated constructs on CaV2.2R52A, R54A HA cell surface expression. Neuro2A cells expressed CaV2.2R52A, R54A
HA/α2δ-1/β1b with CaV3.1 Dom I–II (control), CaV2.2 Dom I–II or CaV2.2 Dom I–IIR52A, R54A. (D) Three examples of confocal images CaV2.2R52A, R54A HA with CaV3.1 Dom I–II (top),
CaV2.2R52A, R54A HA with CaV2.2 Dom I–II (middle) or CaV2.2R52A, R54A HA with CaV2.2 Dom I–IIR52A, R54A (bottom). (E) Cell surface expression was quantiﬁed based on the HA signal.
The data represent mean ± SEM for CaV2.2R52A, R54A HA with CaV3.1 Dom I–II (black, control), CaV2.2R52A, R54A HA with CaV2.2 Dom I–II (red) or CaV2.2R52A, R54A HA with CaV2.2 Dom
I–IIR52A, R54A (blue). Thedatawere pooled from4 independent experiments;more than100 cellswere included in the analysis for each condition. Statistical analysis: ***pb 0.001 vs control.
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Fig. 4. Co-immunoprecipitation of full-length and truncated CaV2.2 is disrupted by the N-terminal construct. A: RepresentativeWestern blot showing proteins immunoprecipitated with
rat anti-HA antibody and immunoblottedwith anti-CaV2.2. tsA-201 cells expressed CaV2.2HA,α2δ-1 andβ1b, togetherwith CaV3.1 Dom I–II (lane 1), CaV2.2 Dom I–II (lane 2), CaV2.2 Dom
I–II plus GFP-CAAX (lane 3) or CaV2.2 Dom I–II plus CaV2.2-(43-95)-CAAX (lane 4). This result is representative of 3 independent experiments. B:Western-blot showing 30 μgWCL of the
same samples shown in A. C: Quantiﬁcation ofWestern blots. Band intensities for CaV2.2 Dom I–II were measured using ImageJ and normalised for expression of full-length CaV2.2 HA for
each condition and relative to the condition of CaV2.2 HA+CaV2.2 Dom I–II (lane 2 in A and B). Data aremean band intensities (+SEM) from three co-immunoprecipitation experiments
from three different transfections. Statistical analysis: ns = non-signiﬁcant difference, **p b 0.01.
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(43-95)-CAAX, indicating that theN-terminus disrupted the association
of full-length CaV2.2 and CaV2.2 Dom I–II. In addition, the presence ofthe N-terminus construct did not affect the total amount of CaV2.2
full-length channel, indicated by the unchanged amount of full-length
channel band in lane 3 and 4 (Fig. 4B).
Fig. 5. Effect of the N-terminus on CaV2.1 current and suppression by EA2. (A–C) Effect of the N-terminal constructs on CaV2.1/β1b/α2δ-1 currents. (A) Representative traces were evoked
by 50 ms step depolarizations between−50 and +60 mV from a holding potential of−80 mV for CaV2.1/α2δ-1/β1b currents, expressed together with GFP-CAAX (black, control), or
CaV2.1-(46-100)-CAAX (blue). (B) Mean current-voltage relationships of CaV2.1 and GFP-CAAX (black squares, control, n = 13) or CaV2.1 and CaV2.1-(46-100)-CAAX (blue triangles,
n = 12). (C) Mean current density at +5 mV± SEM. Statistical analysis: ns = non-signiﬁcant difference. (D–E) Effect of the N-terminal constructs on the suppressive effect of EA2 on
CaV2.1 currents. (D) Representative traces from tsA-201 cells transfected with CaV2.1/β1b/α2δ-1, together with CaV3.1 Dom I–II and GFP-CAAX (black, control), CaV2.1, EA2 and GFP-
CAAX (red) or CaV2.1, EA2 and CaV2.1-(46-100)-CAAX (blue). (E) Mean current-voltage relationships for CaV2.1, CaV3.1 Dom I–II and GFP-CAAX (black squares, control, n = 25),
CaV2.1 and EA2 plus GFP-CAAX (red circles, n = 24) or CaV2.1 and EA2 plus CaV2.1-(46-100)-CAAX (blue circles, n = 15). (F) Mean current density at +5 mV ± SEM. Statistical
analysis: **p b 0.01, ***p b 0.001.
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251S. Dahimene et al. / Neurobiology of Disease 93 (2016) 243–256We next examined whether uncoupling the deleterious interaction
and thus releasing the full-length channel from its association with
the truncated protein by expressing the keyN-terminus residues can re-
store the channel's function and trafﬁcking.
3.4. Co-expression of the free N-terminus did not alter the function of CaV2.1
First, we evaluated whether there was any direct effect of the N-ter-
minal constructs on channel function. When co-transfected with the
full-length channel, the truncated CaV2.1 N-terminus CaV2.1-(46-
100)-CAAX corresponding to CaV2.2-(43-95)-CAAX did not affect
CaV2.1 function, as shown by the unchanged current densities com-
pared to control cells co-transfected with the control protein GFP-
CAAX (control: −75.3 ± 13.0 pA/pF; CaV2.1-(46-100)-CAAX:
−69.0 ± 6.1 pA/pF; Fig. 5A–C). This indicates that the N-terminal frag-
ment, lacking the initial residues 1–45, does not alone interact with the
full-length channel sufﬁciently to cause inhibition.
3.5. Co-expression of the N-terminal construct partially restored the func-
tion of CaV2.1
We next assessed whether the expression of the CaV2.1 N-terminal
construct, CaV2.1-(46-100)-CAAX, might restore CaV2.1 function by in-
terfering with the dominant-negative effect of EA2.
As shown in Fig. 5D–F, co-expression of CaV2.1-(46-100)-CAAX par-
tially reversed the suppression of CaV2.1 current by EA2. Indeed, the
current density was increased 2.4-fold for the condition in which EA2
was co-expressed with CaV2.1-(46-100)-CAAX (control:−85.7 ± 9.0
pA/pF; CaV2.1-(46-100)-CAAX: −56.2 ± 10.7 pA/pF), compared to
the condition in which EA2 was co-expressed with GFP-CAAX
(23.3 ± 4.5 pA/pF; Fig. 5F). It is likely that CaV2.1-(46-100) had this ef-
fect by disrupting or preventing the interaction between the full-length
channel and the EA2 construct.
3.6. Co-expression of the N-terminus construct restored the expression of
CaV2.2 at the cell surface
Wenext wanted to examinewhether the suppression of CaV2.2 traf-
ﬁcking by CaV2.2 Dom I–II is also disrupted by co-expression of the
equivalent CaV2.2 N-terminal peptide. In parallel with the result found
for CaV2.1 currents, we found ﬁrstly that CaV2.2-(43-95)-CAAX, unlike
CaV2.2 Dom I–II, did not alter the cell-surface expression of CaV2.2
when theywere co-expressed, as shown by the unchangedmean inten-
sity of the HA signal at the cell surface (Fig. 6A, B). Furthermore, co-ex-
pression of CaV2.2-(43-95)-CAAX restored CaV2.2 cell surface
expression by decreasing the deleterious effect of CaV2.2 Dom I–II (Fig.
6C, D). These results nicely recapitulate the CaV2.1 results shown in
Fig. 5.
3.7. Co-expression of the N-terminal construct did not restore the function
of CaV2.1
R57A, R59A
Sincewe found in this study that the EA2mutant still exerted a dom-
inant-negative effect on CaV2.1R57A, R59A (Fig. 3A–C), we next examined
whether itwaspossible to perturb this suppressive effect by co-express-
ing CaV2.1-(46-100)-CAAX. We ﬁrst showed that this construct did not
have a direct effect on CaV2.1R57A, R59A currents (control: 114.0 ± 28.0
pA/pF; CaV2.1-(46-100)-CAAX: 110.0±20.0 pA/pF; Fig. 7A–C). Further-
more, the dominant-negative effect of EA2 on CaV2.1R57A, R59A currents
was not signiﬁcantly reversed by CaV2.1-(46-100)-CAAX (control:
109.9 ± 19.2 pA/pF; EA2 + GFP-CAAX: −36.8 ± 6.0; EA2 + CaV2.1-
(46-100)-CAAX: −65.0 ± 8.8 pA/pF; Fig.7D–F). This likely indicates
that the suppressive effect of EA2 on CaV2.1R57A, R59A is more robust,
and less easily disrupted.3.8. Co-expression of CaV2.1 N-terminus restored P/Q current suppressed by
EA2 in DRG neurons
We then examined whether CaV2.1-(46-100)-CAAX could restore
the endogenous P/Q-type current in DRG neurons co-transfected with
the EA2 mutant. Firstly, DRG neurons were transfected with YFP as a
transfection marker and empty vector, EA2 or EA2 plus CaV2.1-(46-
100)-CAAX, and stained with a CaV2.1 antibody that targets the II–III
loop present in EA2, to demonstrate its expression (Fig. 8A). The native
CaV2.1 could not be detected, probably because of its low level of ex-
pression. We performed experiments 4 days after transfection in the
presence of 1 μM nifedipine and 1 μM ω-conotoxin GVIA to block L-
and N-type channels, respectively, in order to isolate native P/Q-type
calcium currents. The electrophysiological data showed that the expres-
sion of EA2 mutant induced, as expected, a reduction of the native P/Q-
type current greater than 50% (control: −66.0 ± 10.9 pA/pF; EA2:
−27.6 ± 4.3 pA/pF; Fig. 8B–D). Importantly, this reduction was almost
completely prevented when CaV2.1-(46-100)-CAAX was co-expressed
(−65.0 ± 8.8 pA/pF; Fig. 8B–D). This ﬁnding further reinforces the
view that keyN-terminal residues interferewith the dominant-negative
effect of EA2.
4. Discussion
In this studywe show for the ﬁrst time that a keyN-terminal peptide
is able to interfere with the suppressive effect of the two domain trun-
cated CaV2 constructs mimicking EA2 mutant channels, and hence par-
tially restore the functional expression of P/Q-type channels. This may
pave the way for development of future treatments to prevent or dis-
rupt the deleterious effect of the truncated channels.
Mutations in the CACNA1A gene encoding the pore-forming subunit
of the CaV2.1 channel cause several neurological disorders, in particular
FMH1, SCA6 andEA2 (Pietrobon, 2010; Jen, 2008). EA2 is a unique chan-
nelopathy, as it is frequently associated with mutations leading to trun-
cation of the protein. Although EA2 is episodic in nature, it may also be
associated with progressive symptoms, and there are limited treatment
options available (Jen, 2008). EA2 is a dominant disorder, and although
haploinsufﬁciency was originally thought to be its cause, there is in-
creasing evidence for a dominant-negative mechanism (Jouvenceau et
al., 2001; Page et al., 2004; Cao et al., 2004; Mezghrani et al., 2008).
Cacna1a knockout mice, and the naturally occurring cacna1a mutant
mouse tottering, have been widely studied and show absence epilepsy,
ataxia and paroxysmal dyskinesia, with progressive loss of cerebellar
Purkinje cells (Fletcher et al., 1996; Fletcher et al., 2001; Shirley et al.,
2008). However the heterozygous knockout and mutant mice show
no evidence of neurodegeneration, and thus the null mutation is reces-
sive (Fletcher et al., 2001), except in the case of the semi-dominant
tottering5J (Miki et al., 2008). Furthermore postnatal knockout of
CaV2.1 in Purkinje cells produces similar effects to the full knockout, in
terms of neurological deﬁcit (Mark et al., 2011). It is also of interest
that siRNA knock-down of P/Q-type channels in adult mouse cerebel-
lum resulted in mild impairment that could be enhanced by activation
of β-adrenoceptors, mimicking stress (Salvi et al., 2014).
Our study conﬁrms that an arginine-alanine-arginine (RAR)motif in
the N-terminus is involved in the suppressive effect of the truncated
channels. Interestingly, we found that disrupting the arginine motif in
the full-length CaV2.1R57A, R59A and CaV2.2R52A, R54A channels did not im-
pede channel function or expression at the cell surface, respectively. It is
also worth mentioning that CaV2.1R57A, R59A evoked a larger current
compared to wild-type CaV2.1. The level of expression of CaV2.1R57A,
R59A and CaV2.2R52A, R54A was found unchanged in respect to the wild
type CaV2.1 and CaV2.2 respectively indicating that these proteins are
not more stable or more highly expressed (data not shown, three inde-
pendent experiments). The larger CaV2.1R57A, R59A current can be ex-
plained by the lack of tonic G-protein inhibition, as it has been shown
that disrupting this motif completely abolished CaV2.2 G-protein
Fig. 6. Effect of the CaV2.2 N-terminus and truncated domains on CaV2.2 HA trafﬁcking. (A) Representative confocal images of Neuro2A cells transfected with CaV2.2 HA/α2δ-1/β1b in the
presence of CaV3.1 Dom I–II (top panel), CaV2.2-Dom I–II (middle panel) or CaV2.2-(43-95)-CAAX (bottom panel). Surface stainingwas obtained using HA antibody in non-permeabilized
cells. (B) CaV2.2 cell surface expression of was quantiﬁed based on the HA signal. Mean cell surface expression ± SEM for CaV2.2 HA and CaV3.1 Dom I–II (black, control), CaV2.2 HA and
CaV2.2-Dom I–II (red) or CaV2.2 HA and CaV2.2-(43-95)-CAAX (blue). The data are pooled from3 independent experiments; more than 50 cells have been included in the analysis for each
condition. Statistical analysis: **p b 0.01, ns=non-signiﬁcant difference. (C) Representative confocal images of Neuro2A cells, showing cell surface expression of CaV2.2HA in the presence
of CaV3.1 Dom I–II and GFP-CAAX (top panel), CaV2.2 HA, CaV2.2-Dom I–II and GFP-CAAX (middle panel) or CaV2.2 HA, CaV2.2-Dom I–II and CaV2.2-(43-95)-CAAX (bottompanel). Surface
staining was obtained by using HA antibody before cell permeabilization. (D) Cell surface expression of CaV2.2 was quantiﬁed based on the HA signal using ImageJ software. Bar chart of
mean± SEM cell surface expression of CaV2.2 HA and CaV3.1 Dom I–II and GFP-CAAX (black), CaV2.2 HA, CaV2.2 Dom I–II and GFP-CAAX (red) or CaV2.2 HA, CaV2.2 Dom I–II and CaV2.2-
(43-95)-CAAX (blue). The data are pooled from 3 independent experiments and more than 50 cells have been included in the analysis for each condition. Statistical analysis: *p b 0.05,
ns = non-signiﬁcant difference.
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suppressed CaV2.2R52A, R54A and CaV2.1R57A, R59A trafﬁcking and currents,
in a similar manner to their effect on the wild-type channels. This indi-
cates that disrupting the RAR motif in the full-length channel does not
impede the deleterious interaction; in contrast, disrupting the same
RARmotif present in the N-terminus of the truncated channels reduced
their ability to produce dominant-negative suppression for both CaV2.1
and CaV2.2.
We postulate that the N-terminus is normally involved in intramo-
lecular dockingwith another part of the same channel, to form correctly
folded and functional channels, and the RAR motif is involved in thisinteraction (Fig. 9A). This intramolecular docking is also involved in G-
protein–mediated inhibition of the CaV2 channels (Page et al., 1998;
Canti et al., 1999).We propose that in the truncated channels this intra-
molecular interaction cannot occur, because the channel structure is in-
complete and misfolded (Fig. 9B), with the consequence that the
exposed N-terminus of the truncated channel is able to participate in
competition for the N-terminal docking site on the full-length channel,
to form a deleterious intermolecular interaction (Fig. 9B, C). When the
RAR motif is mutated in the N-terminus of the truncated channels, it
therefore reduces their ability to interact with docking site on the full
length channel (Fig. 9B, C).
Fig. 7. Effect of the N-terminal construct on CaV2.1R57A, R59A current and suppression by EA2. (A) Representative traces of the currents evoked by CaV2.1R57A, R59A in presence of GFP-CAAX
(black) or CaV2.1-(46-100)-CAAX (blue). (B) Mean current-voltage relationships of CaV2.1 and GFP-CAAX (black squares, n = 11) or CaV2.1 and CaV2.1-(46-100)-CAAX (blue triangles,
n = 12). (C) Mean current density at +5 mV for the two conditions. Statistical analysis: ns = non-signiﬁcant difference. (D–F) Effect of the N-terminal construct on the suppressive
effect of EA2 on CaV2.1R57A, R59A current. (D) Representative traces of tsA-201 cells transfected with CaV2.1R57A, R59A, CaV3.1 Dom I–II and GFP-CAAX for the control condition (black) or
CaV2.1 and EA-2 in the presence of GFP-CAAX (red), or CaV2.1-(46-100)-CAAX (blue). (E) Mean current-voltage relationships of CaV2.1, CaV3.1 Dom I–II and GFP-CAAX (black squares,
n = 14), CaV2.1, EA2 and GFP-CAAX (red circles, n = 26) or CaV2.1, EA2 and CaV2.1-(46-100)-CAAX (blue circles, n = 21). (F) Mean current density at +5 mV ± SEM for CaV2.1,
CaV3.1 Dom I–II and GFP-CAAX (black, n = 10), CaV2.1, EA2 and GFP-CAAX (red, n = 27) or CaV2.1, EA2 and CaV2.1-(46-100)-CAAX (blue, n = 23). Statistical analysis: **p b 0.01,
ns = non-signiﬁcant difference.
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254 S. Dahimene et al. / Neurobiology of Disease 93 (2016) 243–256We have also shown that overexpression of an N-terminal peptide
containing the RAR motif disrupted the deleterious interaction and in-
terferedwith the ability of the truncated domains to suppress trafﬁckingFig. 8. Rescue by the free N-terminus of the suppression by EA2 of endogenous P/Q type curre
vector and YFP (control, top panel), EA2, pcDNA3 empty vector and YFP (middle panel) or EA
stained with CaV2.1 antibody that targets the II–III loop. (B) Representative traces of endogen
YFP (black); EA2 and pcDNA3 empty vector and YFP (red) or EA2, CaV2.1-(46-100)-CAAX and
by 50 ms step depolarizations between−50 and +60 mV from a holding potential of−80 m
transfected with pcDNA3 empty vector and YFP (black squares, n = 13), EA2, pcDNA3 empty
n = 15). (D) Current density at +10 mV ± SEM for pcDNA3 empty vector and YFP (black, n
and YFP (blue, n = 15). Statistical analysis: *p b 0.05, **p b 0.01, ns = non-signiﬁcant differenand functional expression of the full-length channels (as represented in
Fig. 9D). Although this effectwas only partial in overexpression systems,
strikingly, the same N-terminal peptide completely abolished thent in DRG neurons. (A) Confocal images of DRG neurons transfected with empty pcDNA3
2, CaV2.1-(46-100)-CAAX and YFP (bottom panel). The neurons were permeabilized and
ous P/Q current. The DRG neurons were co-transfected with empty pcDNA3 vector and
YFP (blue). The P/Q-type current was isolated pharmacologically. Currents were evoked
V. The charge carrier was 5 mM Ba2+. (C) Current-voltage relationships of DRG neurons
vector and YFP (red circles, n = 10) or EA2, CaV2.1-(46-100)-CAAX and YFP (blue circles,
= 13), EA2, pcDNA3 empty vector and YFP (red, n = 10) or EA2, CaV2.1-(46-100)-CAAX
ce.
Fig. 9. Diagram of the possible mechanism for involvement of the N-terminus in dominant-negative suppression. (A) The four domains of CaV2 channels are shown in light blue, orange,
green and red. The N-terminus is shown interacting with an intramolecular docking site on the left, whereas on the right interaction is reduced bymutation of the RARmotif (**). (B) The
twodomains of the truncated constructs are shown in darkblue and brown. On the right the truncated construct has amutatedRAR (**). (C) TheN-terminus of the truncated construct can
interactwith thedocking site on the full-length channel, initiating aggregation. This interaction is reduced bymutation of theRARmotif. (D) The freeN-terminus interactswith thedocking
site on the full-length channel reducing the ability of the truncated channel to interact with this site.
255S. Dahimene et al. / Neurobiology of Disease 93 (2016) 243–256deleterious effect of the EA2 mutant on the endogenous P/Q-type cur-
rent in DRG neurons. This discrepancy is probably due to the fact that
the interaction occurs very early during protein synthesis in the endo-
plasmic reticulum (Page et al., 2004; Mezghrani et al., 2008). Thus the
complex, comprising full-length and truncated channels, is formed co-
translationally in expression systems, possibly involving additional
sites aswell as the N-terminus, and is retained in the endoplasmic retic-
ulum with limited access to competition for its binding site by the free
N-terminal construct. In contrast in DRG neurons the free N-terminus
is probably expressed in excess compared to the endogenous channels,
and better able to compete with EA2 for the N-terminal docking site on
the full length channel. When the N-terminal RAR motif in the full-
length channel is mutated to AAA, we propose that the intramolecular
interaction of the N-terminus with its own docking site may be weak-
ened (Fig 9A). This would agree with our ﬁnding that the free N-termi-
nus was not able to disrupt the deleterious interaction betweenCaV2.1R57A, R59A and the EA2 mutant, and may indicate that the interac-
tion is more robust and thus more difﬁcult to disrupt.
The intramolecular dockingmechanismwe propose for CaV2 is rem-
iniscent of the role of the tetramerization domain (T1 domain) in the N-
termini of Kv1–Kv4 potassium channels, which has been shown to be
involved with the folding and oligomerization of the channels
(Brueggemann et al., 2013). Oligomerization requires a threshold level
of folding of theN-terminus and it has been suggested that this coupling
between folding and assembly of Kv channels may be a common trait
(Robinson and Deutsch, 2005). The interactions between T1 domains
of Kv1.3 occur very early during protein synthesis in the endoplasmic
reticulum, while the nascent peptides of different subunits are still at-
tached to ribosomes (Lu et al., 2001).
In summarywe have shown that uncoupling the deleterious interac-
tion and thus releasing the full-length channel from its association with
the truncated EA2 channel by expressing the key N-terminus residues
256 S. Dahimene et al. / Neurobiology of Disease 93 (2016) 243–256partially restored channel functional expression in overexpression sys-
tems. More importantly the endogenous P/Q current in native neurons
was fully recovered by expressing the same N-terminal peptide.
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